The bacterial tryptophan reverse mutation assay with Escherichia coli WP2
- PMID: 11113467
- DOI: 10.1016/s0027-5107(00)00076-2
The bacterial tryptophan reverse mutation assay with Escherichia coli WP2
Abstract
The Escherichia coli WP2 tryptophan reverse mutation assay detects trp(-) to trp(+) reversion at a site blocking a step in the biosynthesis of tryptophan prior to the formation of anthranilic acid. The different WP2 strains all carry the same AT base pair at the critical mutation site within the trpE gene. The assay is currently used by many laboratories in conjunction with the Ames Salmonella assay for screening chemicals for mutagenic activity. In general the WP2 strains are used as a substitute for, or as an addition to Salmonella strain TA102 which also carries an AT base pair at the mutation site. The assay is also recommended together with the Ames assay for data submission to regulatory agencies. National and international guidelines have been established for performing these mutagenicity assays. The E. coli WP2 assay procedures are the same as those described elsewhere in this volume for the Ames Salmonella assay (Mortelmans and Zeiger, 2000) with the exception that limited tryptophan instead of limited histidine is used. This chapter is an addendum to the previous chapter and the reader should refer to the previous chapter for details regarding experimental procedures and assay design.
Similar articles
-
Bacterial mutagenicity assays: test methods.Methods Mol Biol. 2012;817:21-34. doi: 10.1007/978-1-61779-421-6_2. Methods Mol Biol. 2012. PMID: 22147566
-
An evaluation of the Escherichia coli WP2 and WP2 uvrA reverse mutation assay.Mutat Res. 1980 Sep;76(2):169-90. doi: 10.1016/0165-1110(80)90009-3. Mutat Res. 1980. PMID: 7005668
-
Comparisons on chemically-induced mutation among four bacterial strains, Salmonella typhimurium TA102 and TA2638, and Escherichia coli WP2/pKM101 and WP2 uvrA/pKM101: collaborative study II.Mutat Res. 1998 Jan 13;412(1):17-31. doi: 10.1016/s1383-5718(97)00155-1. Mutat Res. 1998. PMID: 9508361
-
The Ames Salmonella/microsome mutagenicity assay.Mutat Res. 2000 Nov 20;455(1-2):29-60. doi: 10.1016/s0027-5107(00)00064-6. Mutat Res. 2000. PMID: 11113466 Review.
-
Recommendations for the performance of bacterial mutation assays.Mutat Res. 1994 Jun;312(3):217-33. doi: 10.1016/0165-1161(94)90037-x. Mutat Res. 1994. PMID: 7514736 Review.
Cited by
-
Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen.Mutat Res. 2012 Jul 4;746(1):78-88. doi: 10.1016/j.mrgentox.2012.03.009. Epub 2012 Apr 10. Mutat Res. 2012. PMID: 22498038 Free PMC article.
-
Assessing the effect of N-oxidation on the mutagenicity of 1-pyrazolines using the Ames assay.Toxicol Res (Camb). 2023 May 23;12(3):503-506. doi: 10.1093/toxres/tfad036. eCollection 2023 Jun. Toxicol Res (Camb). 2023. PMID: 37397930 Free PMC article.
-
Are all bacterial strains required by OECD mutagenicity test guideline TG471 needed?Mutat Res Genet Toxicol Environ Mutagen. 2019 Dec;848:503081. doi: 10.1016/j.mrgentox.2019.503081. Epub 2019 Aug 9. Mutat Res Genet Toxicol Environ Mutagen. 2019. PMID: 31708075 Free PMC article.
-
Microbe-mineral interactions in naturally radioactive beach sands from Espirito Santo, Brazil: experiments on mutagenicity.Radiat Environ Biophys. 2007 Aug;46(3):247-53. doi: 10.1007/s00411-007-0100-9. Epub 2007 Mar 15. Radiat Environ Biophys. 2007. PMID: 17361436
-
Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies.Int J Toxicol. 2015 Mar-Apr;34(2):129-37. doi: 10.1177/1091581815569582. Epub 2015 Feb 20. Int J Toxicol. 2015. PMID: 25701764 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources